✦ LIBER ✦

Extended follow-up of outcome measures in multiple myeloma patients treated on a phase I study with bortezomib and pegylated liposomal doxorubicin

✍ Scribed by Suzanne E. Biehn; Dominic T. Moore; Peter M. Voorhees; Reynaldo A. Garcia; Mary Jo Lehman; E. Claire Dees; Robert Z. Orlowski

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase I and pharmacologic study of the

✍ E. Claire Dees; Bert H. O’Neil; Celeste M. Lindley; Frances Collichio; Lisa A. C 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 527 KB

Safety and efficacy of bortezomib and me

✍ James R. Berenson; Hank H. Yang; Robert A. Vescio; Youram Nassir; Russell Mapes; 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 164 KB